2036-0830 Screening compound: N-(3-hydroxyphenyl)-2-(6-{5-[(3-hydroxyphenyl)carbamoyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl}pyridin-2-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide

2036-0830 Screening compound: N-(3-hydroxyphenyl)-2-(6-{5-[(3-hydroxyphenyl)carbamoyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl}pyridin-2-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide
2036-0830 Screening compound: N-(3-hydroxyphenyl)-2-(6-{5-[(3-hydroxyphenyl)carbamoyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl}pyridin-2-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2036-0830
N-(3-hydroxyphenyl)-2-(6-{5-[(3-hydroxyphenyl)carbamoyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl}pyridin-2-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2036-0830

Molecular Formula

C35H21N5O8 (C35 H21 N5 O8)

Compound Name

N-(3-hydroxyphenyl)-2-(6-{5-[(3-hydroxyphenyl)carbamoyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl}pyridin-2-yl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide

IUPAC name

N-(3-hydroxyphenyl)-2-(6-{5-[(3-hydroxyphenyl)carbamoyl]-13-dioxo-23-dihydro-1H-isoindol-2-yl}pyridin-2-yl)-13-dioxo-23-dihydro-1H-isoindole-5-carboxamide

SMILES

Oc1cccc(NC(c(cc2)cc(C(N3c4cccc(N(C(c(cc5)c6cc5C(Nc5cc(O)ccc5)=O)=O)C6=O)n4)=O)c2C3=O)=O)c1

InChI

InChI=1S/C35H21N5O8/c41-22-6-1-4-20(16-22)36-30(43)18-10-12-24-26(14-18)34(47)39(32(24)45)28-8-3-9-29(38-28)40-33(46)25-13-11-19(15-27(25)35(40)48)31(44)37-21-5-2-7-23(42)17-21/h1-17,41-42H,(H,36,43)(H,37,44)

InChI Key

WPUCJTCTEACBER-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00304046

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

639.58

Hydrogen Bond Acceptors Count

15.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

13

Partition Coefficient, logP

4.679

Distribution Coefficient, logD

4.661

Water Solubility, LogSw

-4.41

Polar Surface Area

146.481

Acid Dissociation Constant (pKa)

8.78

Base Dissociation Constant (pKb)

-3.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

2036-0830 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Proteases
  • Phosphatases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 2036-0830 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2036-0830?
Check Price and Availability of 2036-0830, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2036-0830 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2036-0830
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2036-0830
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2036-0830 available by request